Biofil Chemicals and Pharmaceuticals Limited reported earnings results for the second quarter and six months ended September 30, 2022. For the second quarter, the company reported sales was INR 26.2 million compared to INR 137.38 million a year ago. Revenue was INR 26.43 million compared to INR 137.69 million a year ago. Net income was INR 0.455 million compared to INR 2.13 million a year ago. Basic earnings per share from continuing operations was INR 0.03 compared to INR 0.13 a year ago. Diluted earnings per share from continuing operations was INR 0.03 compared to INR 0.13 a year ago.
For the six months, sales was INR 149.25 million compared to INR 191.07 million a year ago. Revenue was INR 149.66 million compared to INR 191.58 million a year ago. Net income was INR 2.52 million compared to INR 3.87 million a year ago. Basic earnings per share from continuing operations was INR 0.15 compared to INR 0.24 a year ago. Diluted earnings per share from continuing operations was INR 0.15 compared to INR 0.24 a year ago.